Chronic lymphocytic leukaemia trials in Hong Kong

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

  Where

  Hong Kong

  Age

  18 years and over

  People

  1,200 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06136559 · EU 2022-501697-19-01
• Phase 2Not yet taking people in Hong Kong
  Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML

  Where

  Hong Kong

  Age

  18 years and over

  People

  45

  Run by

  The University of Hong Kong

  See details and how to joinNCT07493408